The Enterprise Value as of December 2025 (TTM) for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is 6.53B

According to Zhejiang Starry Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.53B. This represents a change of 6.08% compared to the average of 6.16B of the last 4 quarters.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Historical Enterprise Value (quarterly & annually)

How has 603520.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhejiang Starry Pharmaceutical Co.,Ltd. over the last ten years is 8.08B. The current 6.53B Enterprise Value has changed 7.99% with respect to the historical average. Over the past ten years (40 quarters), 603520.SS's Enterprise Value was at its highest in in the September 2020 quarter at 19.84B. The Enterprise Value was at its lowest in in the December 2015 quarter at 1.95B.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhejiang Starry Pharmaceutical Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Average Enterprise Value

How has 603520.SS Enterprise Value performed in the past?

The current Enterprise Value of Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Enterprise Value vs. Peers

How is 603520.SS’s Enterprise Value compared to its peers?

Zhejiang Starry Pharmaceutical Co.,Ltd.’s Enterprise Value is greater than Zhuhai Rundu Pharmaceutical Co., Ltd. (4.70B), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (3.60B), greater than Yabao Pharmaceutical Group Co., Ltd (4.09B), greater than Jinhe Biotechnology Co. Ltd. (6.37B), greater than Tibet Weixinkang Medicine Co., Ltd. (4.36B), greater than Harbin Medisan Pharmaceutical Co., Ltd. (4.66B), greater than LanZhou Foci Pharmaceutical Co.,Ltd. (3.91B), greater than Beijing Beilu Pharmaceutical Co., Ltd (4.69B), greater than Tianjin Tianyao Pharmaceuticals Co., Ltd. (4.67B), greater than ZhuZhou QianJin Pharmaceutical Co.,Ltd (4.07B),

Build a custom stock screener for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Starry Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Starry Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.